Dr. Lal Path Labs Ltd. has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
LALPATHLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Dr. Lal Path Labs has informed the stock exchanges that its trading window for dealing in company securities will be closed starting October 1, 2025. The window will remain shut until 48 hours after the announcement of financial results for the quarter and half year ending September 30, 2025. This is a routine compliance step taken under SEBI's Insider Trading Regulations, 2015 and the company's own insider trading code. Insiders, including directors, employees, and connected persons, are barred from trading in the company's shares during this period.
This is a standard regulatory filing and does not impact business operations. It signals that Q2 and H1 FY26 results are likely to be announced in mid-to-late October 2025, which investors should watch for as the next key catalyst for the stock.